AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimkaire MF 2mg/1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

SAG Health Science Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (1000mg)

Overview Glimkaire MF 2mg/1000mg Tablet SR

Diabex Duo 2mg/1000mg extended-release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabex Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continue taking Diabex Duo even with controlled blood sugar; abrupt cessation can elevate glucose levels, potentially leading to complications like kidney impairment, vision loss, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan, including a balanced diet, regular exercise, and weight management as advised by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Maintain regular mealtimes and carry a readily available fast-acting glucose source (e.g., sugary snacks, fruit juice). Alcohol consumption increases hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Do not use Diabex Duo if you have type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Inform your physician of any history of heart disease before commencing treatment; Diabex Duo may be unsuitable. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring is essential, and your physician may order blood tests to track blood cell counts and liver function.

Uses of Glimkaire MF 2mg/1000mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimkaire MF 2mg/1000mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimkaire MF 2mg/1000mg Sustained-Release tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Glimkaire MF 2mg/1000mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimkaire MF 2mg/1000mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or dividing it. Consume Glimkaire MF 2mg/1000mg Sustained-Release tablets with a meal.

How Glimkaire MF 2mg/1000mg Tablet SR works:

Glimkaire MF 2mg/1000mg Extended-Release tablets combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimkaire MF 2mg/1000mg Tablet SR with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimkaire MF 2mg/1000mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Sustained-release Glimkaire MF tablets (2mg/1000mg) are contraindicated during lactation due to potential infant toxicity.

DrivingDrivingCAUTION

Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use the extended-release Glimkaire MF 2mg/1000mg tablet cautiously, as dose modification may be necessary. Avoid this medication if you have severe kidney disease. Your physician should be consulted, and regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimkaire MF 2mg/1000mg Tablet SR cautiously, potentially requiring dosage modification. Individuals with severe liver disease should avoid this medication. A lower starting dose is usually prescribed for those with mild to moderate liver disease. Physician consultation is advised.

What if you forget to take Glimkaire MF 2mg/1000mg Tablet SR :

Should you forget a Glimkaire MF 2mg/1000mg Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Glimkaire MF 2mg/1000mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Glimkaire MF 2mg/1000mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimkaire MF 2mg/1000mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimkaire MF and seek immediate medical attention.
Glimkaire MF 2mg/1000mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Glimkaire MF 2mg/1000mg Tablet SR may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimkaire MF 2mg/1000mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Glimkaire MF 2mg/1000mg SR Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimkaire MF 2mg/1000mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimkaire MF 2mg/1000mg T...
72
MRP 88
18% off